ALX Oncology Holdings Inc. ALXO

1.31 (0.05) (3.68%) as of 25 Sep
Market cap
$187.4M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
P/E ratio — — — — — 0.00 0.00 0.00 —
P/S ratio — — — — — 653.57 25.44 25.44 —
P/FCF ratio — — — — — 0.00 0.00 0.00 —
P/Operating CF — — — — — (117.03) (15.41) (15.41) —
P/B ratio — — — — — 3.71 0.00 0.00 —
EV/Sales — — — — — 477.83 0.67 0.67 —
EV/EBITDA — — — — — 0.00 0.00 0.00 —
EV/FCF — — — — — (30.40) (0.12) (0.12) —
Current Ratio 2.07 7.26 5.24 9.57 24.00 70.28 1.97 5.45 —
Net Debt/EBITDA 0.34 0.81 0.99 2.00 4.32 10.09 0.19 0.62 —
Debt/Equity 0.38 0.09 0.05 0.04 0.01 0.00 (0.08) 0.00 —
ROE (145.70%) (88.91%) (70.97%) (39.42%) (21.05%) (28.36%) 38.02% 28.43% —
ROA (98.34%) (69.10%) (58.58%) (35.97%) (20.45%) (22.81%) (435.95%) 0.00% —
ROIC 0.00% 0.00% (640.53%) (1,036.13%) (2,661.67%) 0.00% 0.00% 0.00% —
Return on Tangible Assets (371.50%) (113.55%) (102.92%) (50.09%) (23.67%) (11.85%) (409.34%) (187.30%) —
Average Days of Receivables — — — 0.00 — 0.00 40.79 164.58 —
Earnings Yield — — — — — (8.13%) (28.29%) (28.29%) —
Free Cash Flow Yield — — — — — (2.40%) (22.26%) (22.26%) —
Free Cash Flow per Share (1.57) (2.35) (3.06) (2.23) (1.81) (2.07) (4.75) (5.03) —
Book value per Share 0.48 2.18 4.41 6.47 9.01 23.25 (22.96) 0.00 —
Free Cash Flow (84.35) (122.36) (131.64) (90.65) (73.02) (38.32) (14.60) (13.84) —
EV/EBIT — — — — — 0.00 0.00 0.00 —
Other line items

Show all line items

Columns are period end dates